Coenzyme Q sub(10) increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex

CoQ sub(10) has shown a hematological activity for the human and has shown an influence on the host defense system. The T4/T8 ratios of lymphocytes are known to be low in patients with AIDS, ARC and malignancies. We have newly found that 14 ordinary subjects responded to CoQ sub(10) by increases in the T4/T8 ratios and an increase in blood levels of CoQ sub(10). This knowledge and survival of two ARC patients for four-five years on CoQ sub(10) without symptoms, and new data on increasing ratios of T4/T8 lymphocytes in the human by treatment with CoQ sub(10) constitute a rationale for new double blind clinical trials on treating patients with AIDS, ARC and diverse malignancies with CoQ sub(10).